HOME >> MEDICINE >> NEWS
Prospects For Surviving Heart Attack Emergency Improve When Clot-Busting Drugs,,Are Combined With Balloon Pump Inserted In Aorta

ce the balloon is in place, a pump is used to expand and contract it. When the balloon expands, it helps improve delivery of oxygenated blood to all the body's tissues and to the heart muscle itself.

To conduct the retrospective study, the researchers used the National Registry of Myocardial Infarction 2, a data base maintained by Genentech. The researchers identified 21,718 patients who had acute heart attacks and who arrived at the hospital with cardiogenic shock or else developed the condition while in the hospital. Of the 21,178 patients studied, 6993 received the balloon pump treatment.

Cardiogenic shock is a life-threatening condition in which, as a result of the heart's failure to pump, blood pressure drops too low to maintain the functioning of other organs. More often than not, cardiogenic shock leads to death.

Barron says use of a pump may improve delivery of a thrombolytic drug to the site of heart-attack causing clot, thereby boosting prospects for breaking up the clot and restoring blood flow to the oxygen-starved heart.


'"/>

Contact: Jeffrey Norris
jnorris@itsa.ucsf.edu
(415) 476-2557
University of California - San Francisco
30-Mar-1998


Page: 1 2

Related medicine news :

1. Combination Therapy Improves Chances Of Surviving Esophageal Cancer
2. The European Society of Cardiology launches Women at Heart
3. Heart surgeons publish death rates
4. Heart attack treatment gap may be closing for women
5. The Larry King Cardiac Foundation presents The Changing Face of Heart Disease on Feb. 2
6. Brenner Childrens Hospital named to NIH Pediatric Heart Network
7. Heart patients treated by non-cardiologists less likely to receive medications
8. Heart failure patients treated for diabetes with insulin have increase in mortality
9. New research results: Heart jacket shown to be effective
10. Heart surgery patients receive less aggressive discharge care
11. Heart attack, stroke risk overlooked in diabetics

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/24/2017)... ... February 24, 2017 , ... HealthPostures, expert standing desk ... and advantages built into the home office sit stand solution are bold colors, ... to gain the benefits embedded in the TaskMate Go are available 24/7 through ...
(Date:2/24/2017)... ... 2017 , ... Dr. Ronald E. Hawkins, vice president for ... Peter A. Bell, DO, MBA, HPF, FACOEP-dist., FACEP, as the new dean of ... Bell comes to Liberty from the Ohio University Heritage College of Osteopathic Medicine ...
(Date:2/24/2017)... ... February 24, 2017 , ... The narrative in “ Signal ... Schanssema ’s true account of his paramedic experiences. Schanssema describes the tragedies he saw, ... his attempts to overcome them. , Schanssema, initially unsure of the career path he ...
(Date:2/24/2017)... ... ... Fiber Network (IFN) President and CEO Kelly C. Dyer recently announced that he will ... the Management Committee when IFN was originally formed in 2002 where he was ultimately ... of the business plan. He became the first paid employee of IFN in ...
(Date:2/23/2017)... ... February 23, 2017 , ... Thinksport, the most ... Jensie Gran Fondo of Marin. For the second year in a row, cyclists ... sunscreen. , “We are thrilled to provide our safe, non-toxic sunscreen to over ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 2017 Report analyzes the worldwide markets for Endodontic ... for the US, Canada , ... Asia-Pacific , Latin America , and ... the period 2015 through 2022. Also, a six-year historic analysis ... derived from primary and secondary research. Company profiles are primarily ...
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017  This ... US$ Thousand by the following Products: ... analyzed in the report include Pharmaceuticals, and Agrochemicals. The ... Japan , Europe , ... provided for the period 2015 through 2022. Also, a ...
(Date:2/24/2017)... Wyoming , Feb. 24, 2017  Xynomic Pharmaceuticals, ... today announced that it has acquired exclusive worldwide ... potentially best-in-class innovative HDAC inhibitor targeting hematological and ... of 14 Phase 1 and 2 clinical trials ... Asia have already been completed, demonstrating ...
Breaking Medicine Technology:
Cached News: